Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANDU PHARMA vs PANACEA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANDU PHARMA PANACEA BIOTECH SANDU PHARMA/
PANACEA BIOTECH
 
P/E (TTM) x 48.8 -60.9 - View Chart
P/BV x 1.4 0.9 160.4% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 SANDU PHARMA   PANACEA BIOTECH
EQUITY SHARE DATA
    SANDU PHARMA
Mar-23
PANACEA BIOTECH
Mar-23
SANDU PHARMA/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs86191 44.9%   
Low Rs50107 46.9%   
Sales per share (Unadj.) Rs67.675.1 90.1%  
Earnings per share (Unadj.) Rs1.6-5.5 -28.6%  
Cash flow per share (Unadj.) Rs2.10.9 240.2%  
Dividends per share (Unadj.) Rs0.750-  
Avg Dividend yield %1.10-  
Book value per share (Unadj.) Rs40.6137.7 29.5%  
Shares outstanding (eoy) m9.6661.25 15.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.02.0 50.7%   
Avg P/E ratio x43.3-27.1 -159.8%  
P/CF ratio (eoy) x32.3170.0 19.0%  
Price / Book Value ratio x1.71.1 154.8%  
Dividend payout %47.60-   
Avg Mkt Cap Rs m6589,142 7.2%   
No. of employees `000NANA-   
Total wages/salary Rs m1111,265 8.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m6534,599 14.2%  
Other income Rs m3517 0.6%   
Total revenues Rs m6575,116 12.8%   
Gross profit Rs m2547 52.9%  
Depreciation Rs m5391 1.3%   
Interest Rs m144 1.8%   
Profit before tax Rs m22128 17.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7466 1.5%   
Profit after tax Rs m15-337 -4.5%  
Gross profit margin %3.81.0 372.1%  
Effective tax rate %31.4363.5 8.6%   
Net profit margin %2.3-7.3 -31.7%  
BALANCE SHEET DATA
Current assets Rs m2555,623 4.5%   
Current liabilities Rs m1393,297 4.2%   
Net working cap to sales %17.850.6 35.3%  
Current ratio x1.81.7 107.9%  
Inventory Days Days6559 110.2%  
Debtors Days Days26848 561.3%  
Net fixed assets Rs m2867,028 4.1%   
Share capital Rs m9761 157.7%   
"Free" reserves Rs m2968,375 3.5%   
Net worth Rs m3928,436 4.7%   
Long term debt Rs m0202 0.0%   
Total assets Rs m54212,712 4.3%  
Interest coverage x28.73.9 738.6%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.20.4 333.4%   
Return on assets %3.0-2.3 -128.1%  
Return on equity %3.9-4.0 -96.9%  
Return on capital %5.92.0 293.2%  
Exports to sales %043.3 0.0%   
Imports to sales %024.4 0.0%   
Exports (fob) Rs mNA1,992 0.0%   
Imports (cif) Rs mNA1,124 0.0%   
Fx inflow Rs m01,992 0.0%   
Fx outflow Rs m01,191 0.0%   
Net fx Rs m0801 0.0%   
CASH FLOW
From Operations Rs m2-4,225 -0.1%  
From Investments Rs m54,303 0.1%  
From Financial Activity Rs m6-184 -3.2%  
Net Cashflow Rs m13-105 -12.7%  

Share Holding

Indian Promoters % 42.9 73.6 58.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 1.0 1.1%  
FIIs % 0.0 0.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 57.1 26.4 216.2%  
Shareholders   10,021 47,091 21.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANDU PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SANDU PHARMA vs Panacea Biotech

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SANDU PHARMA vs Panacea Biotech Share Price Performance

Period SANDU PHARMA Panacea Biotech S&P BSE HEALTHCARE
1-Day -0.45% -1.74% 1.18%
1-Month -15.08% -20.01% -0.75%
1-Year 9.73% 11.75% 61.82%
3-Year CAGR 19.30% -12.26% 18.16%
5-Year CAGR 21.14% -9.98% 19.79%

* Compound Annual Growth Rate

Here are more details on the SANDU PHARMA share price and the Panacea Biotech share price.

Moving on to shareholding structures...

The promoters of SANDU PHARMA hold a 42.9% stake in the company. In case of Panacea Biotech the stake stands at 73.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SANDU PHARMA and the shareholding pattern of Panacea Biotech.

Finally, a word on dividends...

In the most recent financial year, SANDU PHARMA paid a dividend of Rs 0.8 per share. This amounted to a Dividend Payout ratio of 47.6%.

Panacea Biotech paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of SANDU PHARMA, and the dividend history of Panacea Biotech.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.